3.303
price down icon28.35%   -1.307
after-market 시간 외 거래: 3.70 0.397 +12.02%
loading

Indaptus Therapeutics Inc 주식(INDP)의 최신 뉴스

pulisher
07:12 AM

Comparing Indaptus Therapeutics Inc. in custom built stock radarsTrade Analysis Summary & Short-Term High Return Strategies - Newser

07:12 AM
pulisher
05:33 AM

Indaptus Therapeutics Inc. stock momentum explainedJuly 2025 Trends & Precise Swing Trade Entry Alerts - Newser

05:33 AM
pulisher
01:25 AM

Is Indaptus Therapeutics Inc. forming a bottoming baseEntry Point & Entry Point Confirmation Alerts - Newser

01:25 AM
pulisher
12:52 PM

Order flow analysis tools used on Indaptus Therapeutics Inc.July 2025 Spike Watch & Low Risk Profit Maximizing Plans - Newser

12:52 PM
pulisher
12:38 PM

How to monitor Indaptus Therapeutics Inc. with trend dashboardsEarnings Growth Summary & Safe Entry Trade Signal Reports - Newser

12:38 PM
pulisher
Sep 06, 2025

Using RSI to spot recovery in Indaptus Therapeutics Inc.2025 Big Picture & Fast Gain Swing Alerts - Newser

Sep 06, 2025
pulisher
Sep 06, 2025

Will Indaptus Therapeutics Inc. stock go up soonWeekly Trade Report & AI Powered Buy/Sell Recommendations - Newser

Sep 06, 2025
pulisher
Sep 06, 2025

Can Indaptus Therapeutics Inc. be recession proofEarnings Trend Report & Precise Swing Trade Alerts - خودرو بانک

Sep 06, 2025
pulisher
Sep 05, 2025

Can Indaptus Therapeutics Inc. keep up with sector leadersJuly 2025 Highlights & Target Return Focused Picks - خودرو بانک

Sep 05, 2025
pulisher
Sep 05, 2025

Does Indaptus Therapeutics Inc. have a sustainable dividendMarket Rally & Long-Term Growth Plans - خودرو بانک

Sep 05, 2025
pulisher
Sep 05, 2025

Published on: 2025-09-05 13:40:19 - Newser

Sep 05, 2025
pulisher
Sep 05, 2025

Aug Movers: Is Indaptus Therapeutics Inc. stock influenced by commodity pricesGold Moves & Consistent Profit Trading Strategies - خودرو بانک

Sep 05, 2025
pulisher
Sep 05, 2025

Indaptus reports partial response in cancer patient with Decoy20 By Investing.com - Investing.com Australia

Sep 05, 2025
pulisher
Sep 05, 2025

Indaptus Therapeutics stock falls after mixed clinical trial updates By Investing.com - Investing.com UK

Sep 05, 2025
pulisher
Sep 05, 2025

Indaptus Therapeutics stock falls after mixed clinical trial updates - Investing.com

Sep 05, 2025
pulisher
Sep 05, 2025

How to use Fibonacci retracement on Indaptus Therapeutics Inc.2025 Market Trends & Expert Curated Trade Ideas - Newser

Sep 05, 2025
pulisher
Sep 05, 2025

Evaluating Indaptus Therapeutics Inc. with trendline analysisWeekly Trading Summary & Weekly Stock Breakout Alerts - Newser

Sep 05, 2025
pulisher
Sep 05, 2025

Century Therapeutics shares rise 4.38% premarket after Indaptus Therapeutics reported positive clinical trial results. - AInvest

Sep 05, 2025
pulisher
Sep 05, 2025

How sentiment analysis helps forecast Indaptus Therapeutics Inc.Weekly Gains Report & Fast Exit Strategy with Risk Control - Newser

Sep 05, 2025
pulisher
Sep 05, 2025

Indaptus Therapeutics Inc. stock trend outlook and recovery pathEarnings Miss & High Conviction Investment Ideas - Newser

Sep 05, 2025
pulisher
Sep 04, 2025

Signal strength of Indaptus Therapeutics Inc. stock in tech scannersPortfolio Performance Report & Low Drawdown Momentum Trade Ideas - Newser

Sep 04, 2025
pulisher
Sep 04, 2025

Indaptus Therapeutics provides clinical update - MarketScreener

Sep 04, 2025
pulisher
Sep 04, 2025

Indaptus reports partial response in cancer patient with Decoy20 - Investing.com

Sep 04, 2025
pulisher
Sep 04, 2025

Indaptus Therapeutics Provides Clinical Update - GlobeNewswire

Sep 04, 2025
pulisher
Sep 04, 2025

Cancer Drug Shrinks Liver Metastases: Indaptus's Decoy20 Shows Promise in Urothelial Cancer Patient Study - Stock Titan

Sep 04, 2025
pulisher
Sep 04, 2025

Will Indaptus Therapeutics Inc. stock recover after recent dropProduct Launch & Technical Buy Zone Confirmation - Newser

Sep 04, 2025
pulisher
Sep 04, 2025

Applying big data sentiment scoring on Indaptus Therapeutics Inc.2025 Market Trends & Verified Entry Point Signals - Newser

Sep 04, 2025
pulisher
Sep 03, 2025

Is Indaptus Therapeutics Inc. meeting your algorithmic filter criteriaMarket Performance Recap & High Accuracy Swing Entry Alerts - Newser

Sep 03, 2025
pulisher
Sep 03, 2025

What are Indaptus Therapeutics Inc.’s earnings expectationsJuly 2025 Action & Long-Term Investment Growth Plans - خودرو بانک

Sep 03, 2025
pulisher
Sep 03, 2025

News impact scoring models applied to Indaptus Therapeutics Inc.Market Weekly Review & Fast Entry High Yield Stock Tips - Newser

Sep 03, 2025
pulisher
Sep 03, 2025

Published on: 2025-09-03 05:54:24 - Newser

Sep 03, 2025
pulisher
Sep 03, 2025

What MACD signals say about Indaptus Therapeutics Inc.July 2025 News Drivers & High Accuracy Investment Signals - Newser

Sep 03, 2025
pulisher
Sep 02, 2025

Can Indaptus Therapeutics Inc. sustain its profitabilityJobs Report & Weekly Setup with High ROI Potential - خودرو بانک

Sep 02, 2025
pulisher
Sep 02, 2025

Real time alert setup for Indaptus Therapeutics Inc. performanceJuly 2025 Sentiment & Technical Confirmation Alerts - Newser

Sep 02, 2025
pulisher
Sep 02, 2025

Indaptus Therapeutics to Present at the H.C. Wainwright 27ᵗʰ Annual Global Investment Conference - GlobeNewswire

Sep 02, 2025
pulisher
Sep 02, 2025

Biotech Indaptus Therapeutics Joins Major Healthcare Conference: CEO to Present Latest Developments - Stock Titan

Sep 02, 2025
$86.64
price up icon 1.40%
$27.54
price up icon 0.58%
$25.98
price up icon 9.16%
$112.46
price up icon 8.66%
$145.10
price up icon 1.80%
biotechnology ONC
$341.80
price up icon 7.24%
자본화:     |  볼륨(24시간):